OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rise of the natural red pigment ‘prodigiosin’ as an immunomodulator in cancer
Mohammed Moustapha Anwar, Chris Albanese, Nadia Μ. Hamdy, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

Functional dyeing of cellulose macromolecule/synthetic fibers two-component fabrics with sustainable microbial prodigiosins
Qiumeng Zheng, Wenjing Zhang, Lei Wang, et al.
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134964-134964
Closed Access | Times Cited: 25

Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer
Mona M. Elanany, Dina Mostafa, Nadia Μ. Hamdy
Life Sciences (2023) Vol. 330, pp. 121997-121997
Closed Access | Times Cited: 25

Advancing (-)-Premarineosin A as a Potent Antimalarial Therapeutic via Metabolic Engineering and Late-Stage Derivatization
Christina M. McBride, Morgan McCauley, Natalia R. Harris, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access

Advanced Technologies for Large Scale Supply of Marine Drugs
Henar Martínez, Mercedes Santos, Lourdes Pedraza, et al.
Marine Drugs (2025) Vol. 23, Iss. 2, pp. 69-69
Open Access

Cancer therapy with the viral and bacterial pathogens: The past enemies can be considered the present allies
Niloofar Kiaheyrati, Abouzar Babaei, Reza Ranji, et al.
Life Sciences (2024) Vol. 349, pp. 122734-122734
Closed Access | Times Cited: 4

Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future Therapeutics
Daniil Sokolov, Neha Sharda, Aindrila Banerjee, et al.
Current Pharmaceutical Design (2023) Vol. 30, Iss. 1, pp. 31-47
Closed Access | Times Cited: 10

Decylprodigiosin: a new member of the prodigiosin family isolated from a seaweed-associated Streptomyces
Mariana Girão, Sara Freitas, Teresa P. Martins, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2

RETRACTED: Mechanistic insight into the bioactivity of prodigiosin-entrapped lipid nanoparticles against triple-negative breast, lung and colon cancer cell lines
Thaddeus Harrison Gugu, Osita C. Eze, Franklin C. Kenechukwu, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e16963-e16963
Open Access | Times Cited: 4

Red bioactive pigment from Himalayan Janthinobacterium sp. ERMR3:09: optimization, characterization, and potential applications
Srijana Mukhia, Anil Kumar, Rakshak Kumar
Archives of Microbiology (2023) Vol. 206, Iss. 1
Closed Access | Times Cited: 2

Enzyme-responsive mannose-grafted magnetic nanoparticles for breast and liver cancer therapy and tumor-associated macrophage immunomodulation
Gholam Hossein Darya, O Zare, Hamid Reza Karbalaei‐Heidari, et al.
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 4, pp. 663-677
Closed Access

Natural products as promising modulators of breast cancer immunotherapy
Aljawharah Alqathama
Frontiers in Immunology (2024) Vol. 15
Open Access

Pigments from pathogenic bacteria: a comprehensive update on recent advances
Kusumita Acharya, Swarna Shaw, Sudipta Paul Bhattacharya, et al.
World Journal of Microbiology and Biotechnology (2024) Vol. 40, Iss. 9
Closed Access

Microbial Pigments: A Potential Substitute of Synthetic Colorants in the Food and Healthcare Sectors
Niralee Patel, Anjisha Maharshi, Nikitasinh Gohil
(2024), pp. 191-220
Closed Access

Oncogene-addicted solid tumors and microbiome—lung cancer as a main character: a narrative review
Mora Guardamagna, May-Lucie Meyer, Miguel‐Ángel Berciano‐Guerrero, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 8, pp. 2050-2066
Open Access

Mimicking Marine Conditions to Improve Prodigiosin Yields in Bioreactor
Ricardo F. S. Pereira, Carla C. C. R. de Carvalho
Processes (2024) Vol. 12, Iss. 9, pp. 1794-1794
Open Access

CircRNAs: Orchestrating Obesity, Thermogenesis, and Obesity-Associated Cancer Pathways
Nadia Μ. Hamdy, Mohamed Bakr Zaki, Sherien M. El‐Daly, et al.
Interdisciplinary cancer research (2024)
Closed Access

Harnessing bacterial metabolites for enhanced cancer chemotherapy: unveiling unique therapeutic potentials
Aroni Chatterjee, Rajni Khan, Triparna Mukherjee, et al.
Archives of Microbiology (2024) Vol. 206, Iss. 11
Closed Access

Prodigiosin Demonstrates Promising Antiviral Activity Against Dengue Virus and Zika Virus in In‐silico Study
Tanjilur Rahman, Mohammed Sajjad Hossain Bappi, Tanim Jabid Hossain
Analytical Science Advances (2024) Vol. 5, Iss. 11-12
Open Access

Bacterial Pigment Prodigiosin as Multifaceted Compound for Medical and Industrial Application
Ivan Guryanov, Ekaterina Naumenko
Applied Microbiology (2024) Vol. 4, Iss. 4, pp. 1702-1728
Open Access

Comprehensive overview on preparation and diverse applications of prodigiosin nanocomposites
Thi Hanh Nguyen, San‐Lang Wang, Van Bon Nguyen
Research on Chemical Intermediates (2024)
Closed Access

Page 1

Scroll to top